Stock Events

Stock Events

Bristol-Myers Squibb 

$56.92
8682
-$0.46-0.8% Tuesday 20:00

Statistics

Day High
57.48
Day Low
56.73
52W High
62.37
52W Low
42.6
Volume
10,666,278
Avg. Volume
-
Mkt Cap
115.92B
P/E Ratio
16.31
Dividend Yield
4.43%
Dividend
2.52

Upcoming

3
JUL
Dividend Ex
Estimated
 
3
AUG
Dividend Payment
Estimated
 
5
OCT
Dividend Ex
Estimated
 
3
NOV
Dividend Payment
Estimated
 
4
JAN 27
Dividend Ex
Estimated
 

Dividends

4.43%Dividend Yield
May 26
$0.63
Feb 26
$0.63
Nov 25
$0.62
Aug 25
$0.62
May 25
$0.62
10Y Growth
8.26%
5Y Growth
11.38%
3Y Growth
3.39%
1Y Growth
1.61%

Earnings

30JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
1.09
1.33
1.56
1.8
Expected EPS
1.612543
Actual EPS
N/A

Financials

14.64%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
96.39BRevenue
14.11BNet Income

Analyst Ratings

62Average Price Target
The highest estimate is 75.00.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy
46%
Hold
46%
Sell
8%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BMY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer competes directly in various therapeutic areas including oncology, immunology, and cardiovascular diseases.
Merck
MRK
Mkt Cap277.02B
Merck & Co. is a key competitor in the pharmaceutical industry, especially in the oncology segment with its blockbuster cancer drug Keytruda.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson competes across multiple segments including pharmaceuticals, with a strong presence in immunology and oncology.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie competes in areas like immunology and oncology, directly challenging Bristol-Myers Squibb's product lineup.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, with a focus on respiratory diseases, HIV, and vaccines.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that competes in various therapeutic areas including cardiovascular, oncology, and immunology.
AMGEN
AMGN
Mkt Cap178B
Amgen competes in the biopharmaceutical sector, focusing on human therapeutics, including treatments for cancer and cardiovascular disease.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes in the global pharmaceutical market, with a focus on diabetes, oncology, and rare diseases.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, with a strong emphasis on oncology and immunology.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca is a global, science-led biopharmaceutical business that competes in core areas of healthcare, including oncology, cardiovascular, renal, and metabolism.

About

There is no Profile data available for BRM.SG.
Show more...
CEO
Dr. Christopher S. Boerner Ph.D.
Employees
34100
Country
United States
ISIN
US1101221083

Listings

MI
IT
1BMY.MI
STU
DE
BRM.STU
MU
DE
BRM.MU
XETRA
DE
BRM.XETRA

0 Comments

Share your thoughts

FAQ

What is Bristol-Myers Squibb stock price today?▼
The current price of BMY is $56.92 USD — it has decreased by -0.8% in the past 24 hours. Watch Bristol-Myers Squibb stock price performance more closely on the chart.
What is Bristol-Myers Squibb stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bristol-Myers Squibb stocks are traded under the ticker BMY.
Is Bristol-Myers Squibb stock price growing?▼
BMY stock has fallen by -1.16% compared to the previous week, the month change is a -4.06% fall, over the last year Bristol-Myers Squibb has showed a +19.66% increase.
What is Bristol-Myers Squibb market cap?▼
Today Bristol-Myers Squibb has the market capitalization of 115.92B
When is the next Bristol-Myers Squibb earnings date?▼
Bristol-Myers Squibb is going to release the next earnings report on July 30, 2026.
What were Bristol-Myers Squibb earnings last quarter?▼
BMY earnings for the last quarter are 1.58 USD per share, whereas the estimation was 1.42 USD resulting in a +10.99% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bristol-Myers Squibb revenue for the last year?▼
Bristol-Myers Squibb revenue for the last year amounts to 96.39B USD.
What is Bristol-Myers Squibb net income for the last year?▼
BMY net income for the last year is 14.11B USD.
Does Bristol-Myers Squibb pay dividends?▼
Yes, BMY dividends are paid quarterly. The last dividend per share was 0.63 USD. As of today, Dividend Yield (FWD)% is 4.43%.
How many employees does Bristol-Myers Squibb have?▼
As of May 06, 2026, the company has 34,100 employees.
In which sector is Bristol-Myers Squibb located?▼
Bristol-Myers Squibb operates in the Health & Wellness sector.
When did Bristol-Myers Squibb complete a stock split?▼
Bristol-Myers Squibb has not had any recent stock splits.
Where is Bristol-Myers Squibb headquartered?▼
Bristol-Myers Squibb is headquartered in Princeton, United States.